Autoradiographic localization of [3H]RU 486 and [3H]progesterone in the uterus, pituitary and hypothalamus of the rat.
Twenty-one castrated oestrogen-primed Wistar rats, which were 2-months-old, were injected via the jugular vein with 100 mu Ci/100 g body weight of [3H]RU 486 or [3H]progesterone. Some of these received unlabelled compounds for competition studies. Samples of reproductive tract, pituitary and hypothalamus were excised after 15 min. The 4-microns frozen sections were processed for thaw-mounted autoradiography. The exposure time of the autoradiogram was approximately 6 months. After the injection of [3H]RU 486 and [3H]progesterone, the nuclear concentration of radioactivity was most distinct in muscular and stromal cells of the uterus, and the epithelial nuclei of lumina and glands showed weak labelling. Nuclear localization was also observed in muscle cells of the vagina, cervix and oviduct. After injection of [3H]progesterone, the radioactivity was found in the nuclei and cytoplasm of anterior pituitary cells and some cells showed a preferential nuclear concentration of radioactivity. The distribution of [3H]RU 486 in the anterior pituitary was more extensive than that of [3H]progesterone. In the hypothalamus, specific localization of [3H]RU 486 and [3H]progesterone existed in neurones accumulated in the preoptic nucleus, preoptic suprachiasmatic nucleus and the periventricular nucleus. No localization was found in the diaphragm. Pretreatment with RU 486, but not with dexamethasone, reduced the nuclear concentration of radioactivity of [3H]progesterone in the vagina, uterus, oviduct, pituitary and hypothalamus. The nuclear concentration of radioactivity after injection of [3H]RU 486 was also decreased by preinjection with progesterone. The autoradiographic results suggest that RU 486 and progesterone competed for the specific binding site (possibly a progesterone receptor) in the target cells at the levels of the uterus, pituitary and hypothalamus in vivo.
Shi
W L
WL
National Research Institute for Family Planning, Beijing, China.
Zhu
P D
PD
D000818:Animals; D001345:Autoradiography; D002467:Cell Nucleus / Q000032:analysis; D003593:Cytoplasm / Q000032:analysis; D003907:Dexamethasone / Q000494:pharmacology; D004848:Epithelium / Q000032:analysis / Q000648:ultrastructure; D005260:Female; D007031:Hypothalamus / Q000032:analysis* / Q000648:ultrastructure; D015735:Mifepristone / Q000032:analysis* / Q000493:pharmacokinetics; D009132:Muscles / Q000032:analysis / Q000648:ultrastructure; D010052:Ovariectomy; D010902:Pituitary Gland / Q000032:analysis* / Q000648:ultrastructure; D010903:Pituitary Gland, Anterior / Q000032:analysis; D011374:Progesterone / Q000032:analysis* / Q000493:pharmacokinetics / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution; D014316:Tritium; D014599:Uterus / Q000032:analysis* / Q000648:ultrastructure
D014316:Tritium; D015735:Mifepristone; D011374:Progesterone; D003907:Dexamethasone